This network meta-analysis investigates the effects of seven immune checkpoint inhibitor (ICI) drugs on all-grade treatment-related adverse events (TrAEs). It aimed to provide a safety ranking of the ICI drugs for the treatment of cancer.
data("dat.xu")A dataset of network meta-analysis with binary outcomes, containing 23 studies and 7 treatments.
sidstudy IDs.
tidtreatment IDs.
revent counts.
nsample sizes.
Treatment IDs represent: 1) conventional therapy; 2) nivolumab; 3) pembrolizumab; 4) two ICIs; 5) ICI and conventional therapy; 6) atezolizumab; and 7) ipilimumab.